|Bid||116.75 x 100|
|Ask||118.00 x 500|
|Day's Range||116.97 - 117.92|
|52 Week Range||94.42 - 127.64|
|PE Ratio (TTM)||44.22|
|Earnings Date||Jul 26, 2017 - Jul 31, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||141.71|
These three healthcare stocks might be great buys for savvy investors.
Key highlights in the biotech sector include FDA approval for Regeneron's (REGN) Kevzara and data from Amgen and Celgene.
Upcoming AWS Coverage on Regeneron Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / May 24, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ) ...